mRNA vaccine responses in PLWH
mRNA vaccine responses in PLWH
批准号:
10687989
负责人:
JOEL N BLANKSON
金额:
$20.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-22 至 2024-07-31
关键词:
2019-nCoVAffinityAntibodiesAntibody ResponseAntibody titer measurementAntigensAvidityBindingCD4 Positive T LymphocytesCOVID-19COVID-19 vaccinationClonal ExpansionCoinCommon ColdCoronavirusCoronavirus InfectionsDataDevelopmentFutureGeneral PopulationImmunizationImmunizeIndividualInfectionInfluenza A Virus, H1N1 SubtypeLymphocyteMemoryMemory B-LymphocyteMessenger RNAOutcomePatientsPeptidesPoliciesRNA vaccinationRNA vaccineRespiratory DiseaseSARS-CoV-2 B.1.1.7SARS-CoV-2 antibodySARS-CoV-2 antigenSARS-CoV-2 immunitySARS-CoV-2 spike proteinT cell responseT memory cellT-LymphocyteT-cell receptor repertoireTestingUpper Respiratory InfectionsVaccinatedVaccinationVaccinesVariantVirusbooster vaccinecoronavirus diseasecross reactivityefficacy evaluationhuman coronavirusinfluenza virus strainmortalitypathogenphrasesreceptorresponseseroconversionvaccine efficacyvaccine responsevariants of concern
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Two mRNA COVID vaccines that have greater than 90% efficacy in healthy donors have
been developed. However the efficacy of these vaccines in PLWH is unknown. PLWH
have had suboptimal responses to some prior vaccines potentially because they make
limited naïve T cell responses. We and others have shown T cell cross-recognition of
spike proteins from SARS-CoV-2 and the common cold coronavirus and demonstrated
that these cross-reactive responses are less effective against SARS-CoV-2 than mono-
reactive responses. We hypothesize that cross-reactive memory responses will
contribute more towards the total SARS-CoV-2 responses in PLWH than in healthy
donors and this will result in less effective responses to the mRNA vaccines. We will test
this hypothesis by comparing CD4+ T cell and antibody responses in vaccinated healthy
donors and PLWH. Our results will have major implications for future policies regarding
booster shots for PLWH and the general population
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Eradication of clonally expanded CD4+ T cells
-
批准号:10621808
-
项目类别:
-
资助金额:$20.47万
-
财政年份:2022
-
负责人:JOEL N BLANKSON
-
依托单位:
Eradication of clonally expanded CD4+ T cells
-
批准号:10548015
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2022
-
负责人:JOEL N BLANKSON
-
依托单位:
mRNA vaccine responses in PLWH
-
批准号:10402541
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2022
-
负责人:JOEL N BLANKSON
-
依托单位:
Optimization of high throughput viral outgrowth assays for the detection of HIV-1 reservoirs
-
批准号:10177855
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2018
-
负责人:JOEL N BLANKSON
-
依托单位:
A mouse viral outgrowth assay for the detection of residual HIV-1 reservoirs
-
批准号:9298573
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2015
-
负责人:JOEL N BLANKSON
-
依托单位:
A mouse viral outgrowth assay for the detection of residual HIV-1 reservoirs
-
批准号:8965588
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2015
-
负责人:JOEL N BLANKSON
-
依托单位:
Phenotypic analysis of latently infected CD4+ T cells.
-
批准号:8713921
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2013
-
负责人:JOEL N BLANKSON
-
依托单位:
Phenotypic analysis of latently infected CD4+ T cells.
-
批准号:8610757
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2013
-
负责人:JOEL N BLANKSON
-
依托单位:
Analysis of HIV-1 in mucosal tissue in elite suppressors
-
批准号:8209611
-
项目类别:
-
资助金额:$23.43万
-
财政年份:2011
-
负责人:JOEL N BLANKSON
-
依托单位:
Analysis of HIV-1 in mucosal tissue in elite suppressors
-
批准号:8333997
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2011
-
负责人:JOEL N BLANKSON
-
依托单位:
CD8+ T cell mediated inhibition of HIV-1 replication in Elite Suppressors
-
批准号:8013541
-
项目类别:
-
资助金额:$32.15万
-
财政年份:2009
-
负责人:JOEL N BLANKSON
-
依托单位:
CD8+ T cell mediated inhibition of HIV-1 replication in Elite Suppressors
-
批准号:7684560
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2009
-
负责人:JOEL N BLANKSON
-
依托单位:
CD8+ T cell mediated inhibition of HIV-1 replication in Elite Suppressors
-
批准号:8212175
-
项目类别:
-
资助金额:$32.15万
-
财政年份:2009
-
负责人:JOEL N BLANKSON
-
依托单位:
CD8+ T cell mediated inhibition of HIV-1 replication in Elite Suppressors
-
批准号:7769479
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2009
-
负责人:JOEL N BLANKSON
-
依托单位:
CD8+ T cell mediated inhibition of HIV-1 replication in Elite Suppressors
-
批准号:8879353
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2008
-
负责人:JOEL N BLANKSON
-
依托单位:
Characterization of HIV excape mutants and T cell responses in elite suppressors
-
批准号:7474853
-
项目类别:
-
资助金额:$28.12万
-
财政年份:2007
-
负责人:JOEL N BLANKSON
-
依托单位:
Latent virus and HIV-1 specific immunity in LTNPs
-
批准号:7110268
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2002
-
负责人:JOEL N BLANKSON
-
依托单位:
Latent virus and HIV-1 specific immunity in LTNPs
-
批准号:6450960
-
项目类别:
-
资助金额:$11.53万
-
财政年份:2002
-
负责人:JOEL N BLANKSON
-
依托单位:
Latent virus and HIV-1 specific immunity in LTNPs
-
批准号:6787316
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2002
-
负责人:JOEL N BLANKSON
-
依托单位:
Latent virus and HIV-1 specific immunity in LTNPs
-
批准号:6924043
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2002
-
负责人:JOEL N BLANKSON
-
依托单位:
海外基金